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With the availability of complete genome sequence, emphasis has 
shifted towards the understanding of protein function. Two-dimensional gel 
electrophoresis (2D-GE) is a state-of-the-art technique currently used for 
large-scale studies of proteomes from different organisms.  Due to its limited 
resolution of detection (detecting 1000-5000 proteins), this technique alone, 
however, is not sufficient to study complex proteomes, such as that of human 
(>40,000 proteins).  Thus, there is an urgent need to develop a so-called sub-
proteomic approach which is capable of analyzing, with higher-resolution, 
subsets of proteins in a proteome.  
We have developed a functional proteomic methodology that makes 
use of a combination of an emerging technology, DIGE and fluorescent 
probes. The probes are made up of fluorophosphonates (FP) which are 
mechanism-based suicide inhibitors of serine hydrolases. In DIGE, two pools 
of proteins are labeled with 1-(5-carboxypentyl)-1-propylindocarbocyanine 
halide (Cy3) FP probe and 1-(5- carboxypentyl)-1-methylindodi-carbocyanine 
halide (Cy5) FP probe, respectively. The labeled proteins are mixed and 
separated in the same 2D gel, allowing quantification of differential serine 
hydrolases expression. Using Gateway Technology by Invitrogen, a known 
serine hydolase was introduced into the bacterial expression host. Differences 
 vi
in expression of the serine hydrolase between induced and uninduced 
condition were quantified by 2D DIGE. This methodology was further 
extended into quantifying differences in the expression of serine hydrolases 
between normal and apoptotic cells.  
In another part of the project, we report efficient labeling of caspases 
expressed inside apoptotic HeLa cells using fluorescently-labeled or 
biotinylated, fluoromethylketone (fmk)-containing probe. Preliminary results 
with these probes indicated that they were highly cell-permeable, and caspase-
8 has been identified by biotinylated fmk-containing probe. 
In conclusion, 2D DIGE, in combination with fluorescent probes and 
MS, will become a powerful tool for molecular characterization of cancer 
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C h a p t e r  1  
INTRODUCTION 
1.1 Post-genomic era and its challenges 
Over the past two decades, there is an increasing number of prokaryotic and 
eukaryotic organisms being sequenced. From a 49-kbp (base pair) bacteriophage lambda 
genome (Sanger F. et al., 1982) to a 2.91-billion bp human genome (Venter J.C. et al., 
2001), these, nevertheless, provide an exciting blueprint to understand cell biology. 
However, these huge sets of DNA sequences are insufficient, as it is known that proteins are 
ultimately responsible for most processes that take place within the cells. Therefore, 
PROTEOMICS (the analysis of the entire PROTEin complement expressed by a genOME), 
as defined by Marc Wilkins and Keith Williams (1996), grow increasingly important in the 
post-genomics era (Fields S. et al., 2001).  
It has been estimated that the human proteome could contain from as few as 
100,000 different proteins, to as many as a few million. By studying the dynamic 
description of gene regulation, proteomics techniques offers a powerful tool to unravel 
gene functions, holding promises to significantly impact our understanding of the 
molecular composition and function of cells. The changes in protein profiles, for example 
under the influence of different signals, bacterial/viral infection, or environmental factors, 
can be monitored and quantitated. These will provide a powerful tool to identify proteins 
that can be potential targets for diagnostic or therapeutics. 
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Presently, the most sophisticated strategy to globally profile proteome is 2DE-MS, 
which combines 2D-GE, mass spectrometry (MS) and sequence database analysis. (Jessani 
N. et al., 2002) Proteins are resolved as spots and cleaved proteolytically. The resulting 
peptides are subjected to mass spectrometric analyses, followed by respective ‘mass-map’ 
(or ‘mass-fingerprint’) and ‘sequence-tag’ searches in protein sequence databases for 
identification.  
Despite its wide application, this strategy is not without limitations. Firstly, when 
comparing protein differences between two samples, comparison of images from at least 2 
different gels must be made. But because of variations between gels, due to subtle changes 
in experimental conditions, no two gel images are directly superimposable. Very often,     
each sample must be run on several replicate gels to generate electronic ‘average’ gels 
which can then be compared. As a result, high through-put analysis of many samples 
becomes tedious and impractical and subtle changes in the number of proteins and their 
expression levels between samples might be easily overlook. Secondly, current detection 
methods of 2DE rely on staining methods like Coomassie blue and silver staining. The 
latter, though being more sensitive and widely used, but it is still unsuitable for accurate 
quantitative analysis due to its limited dynamic range. Therefore, 2D-GE can only be used 
to analyze a small fraction of highly abundant proteins (<5000) in a proteome (Gygi S.P. 
et al., 2000). Membrane-bound and low abundance proteins, which are frequently the 
protein interest of many researchers, have proven difficult to be analyze by 2D-GE, 
thereby rendering the technique insufficient for large-scale protein profiling in human. 
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1.2 Addressing the proteomic challenges 
In this section, two strategies that have been developed to address the two 2D-GE 
limitations mentioned above will be presented.    
1.2.1 Differential in-gel electrophoresis (DIGE) 
DIGE has been developed by Unlu M. et al (1997) to address the issue on 
difficulties of superimposing two 2D gels. This technique relies on pre-electrophoretic 
labeling of each of the comparing samples with one of the three spectrally distinct 
fluorescent dyes, Cyanine-2 (Cy2), Cyanine-3 (Cy3), and Cyanine-5 (Cy5). The dyes have 
an NHS-ester reactive group and are designed to covalently attach to epsilon amino group 
of lysine of proteins via an amide linkage. 
 The labeled samples are then quenched, mixed and run on a single gel. Because the 
dyes are structurally similar, same proteins from different samples will co-migrate as same 
spots on the same gel. Quantitation of differential protein expression is made easy by 
viewing the gel at different wavelengths and by comparing the intensity difference of the 
two different labels on the same spot (Figure 1). This positional reproducibility means 
image overlay rapidly shows any difference in protein levels between samples, and also 
accelerates image analysis, enabling higher sample throughput. 
In addition, there are other advantages for DIGE over conventional 2D-GE. First, 
optimized DIGE technology is capable of detecting about half as many proteins as 
conventional silver staining, or four times as many proteins as colloidial Coomassie Blue 
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staining (Tonge R. et al., 2001). It has been reported that DIGE is able to detect down to at 
least 500 pg of a protein (Orange P. et al., 2000). Second, DIGE has a linear response to 
variation in protein concentration over four orders of magnitude (104) (Tonge R. et al., 
2001). This enables DIGE to provide more accurate quantitative data in less time than is 
achieved with traditional silver staining, which is only linear over 60-100 fold differences in 
protein concentration (Patton W. et al., 2000; Orange P. et al., 2000) 
To date, DIGE has been successfully used to profile changes in protein expression in 
several toxicity studies (Ruepp S.U. et al, 2002, Smith D.R. et al, 2003) and in comparison 
between normal and cancer/diseased cells (Gharbi S. et al, 2002, Zhou G. et al 2002, Lee 
J.R. et al, 2003, Yamanaka H. et al, 2003) In one of the works by Zhou G. et al (2002), 
DIGE was applied to quantify the differences between laser capture microdissection-
procured esophageal carcinoma cells and normal epithelial cells. Of the detected proteins, 
58 spots were up-regulated by >3-fold and 107 were down-regulated by >3-fold in cancer 
cells. They have shown that 2D DIGE when combine with mass spectrometry can be a 
powerful tool for molecular characterization of cancer progression and identification of 
cancer-specific protein markers.  
In another work by Hu et al (2003), they reported the first case to explore the high-
throughput feature of DIGE, which detect changes in the yeast proteome under 15 
different metal stresses. About 50 yeast proteins which were either up-regulated or down-
regulated during the metal stresses were identified. 
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Protein extract 1  Protein extract 2 
Label with fluorochome 1 Label with fluorochome 2 
Mix labeled extracts 
Separate by 2D electrophoresis 
Image gel 
Excitation wavelength 1 Excitation wavelength 2 
Image analysis and data quantification 
Image overlay Image subtraction 
  
                               Figure 1 Strategy of 2D DIGE 
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1.2.2 Sub-proteomic expression profiling of proteins using activity-based probes (ABPs) 
As mentioned before, more than 100 000 proteins are expected from the genome 
and millions of protein-protein interactions are possible in protein complexes and 
networks. Hence, fractionating the proteome into manageable and physiologically relevant 
subsets becomes relevant and critical. This can be made possible with the use of activity-
based probe (ABP), which has been developed to globally profile a subset of a proteome 
(sub-proteome). Generally, ABP are made up of three units: reactive unit, linker/recognition 
unit and tag unit (Figure 2). The components and functions of each unit will be elaborated in 
following sections. Each type of probe labels or isolates only a specific class of enzymes. 
For example a fluorophosphonate (FP) probe synthesized by Cravatt’s group targets the 
serine hydrolase family of enzyme (Liu Y. et al. 1999), while another probe synthesized by 
Bogyo’s group targets the papain family of cysteine proteases (Greenbaum D. et al., 2002).  
 
Reactive unit Linker/Recognition unit Tag 
 
Figure 2 General structure of an activity-based probe 
1.2.2.1 Reactive unit 
An ideal ABP should be able to carry out specific labeling reactions on ONLY its 
targeting proteins present in a complex proteome, and after which, the protein-probe 
complexes be able to withstand harsh washing conditions during purification steps, as well 
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as denaturing conditions during gel-based separation of probe-labeled proteins from 
unlabeled proteins.  This can only occur when an irreversible complex is formed between 
the probe and targeting enzyme, typically as a result of covalent reactions.  In cases where 
non-covalent complex is formed, the enzyme loses its 3-dimensional structure under the 
denaturing conditions, readily detach itself from the probe, leading to subsequent 
dissociation of the complex.  Consequently, the main function of the reactive units within 
the ABP is to ensure irreversible, covalent bonds are formed between the probe and 
enzymes it targets.  The reactive units in ABPs are made up of mechanism-based substrates 
or suicide inhibitors, which label enzymes during the catalytic process.   
The chemical groups on different reactive units may be fine tuned to target different 
classes of enzymes based on their enzymatic activity under a complex background of other 
enzymes in a proteome.  Most ABPs use electrophilic chemical groups as their reactive 
units, which, upon binding to the enzymes, are able to selectively, as well as covalently, 
modify the active sites of the enzymes (Jeffery D.A. et al. 2002).  This strategy is quite 
general, as most, if not all, enzymes invariably contain nucleophilic groups within their 
active sites, which provide good “electrophilic traps” for the reactive unit in the probe.  
The ABPs reported thus far can be divided into two types, based on mechanisms by 
which their reactive units covalently label the enzymes. The first type is true mechanism-
based probes which is designed by using actual enzyme mechanism as blueprint and is able 
to covalently modify the enzyme catalytic center. Examples of such ABP include: 
epoxysuccinyl derivatives, acyloxymethyl ketones, and peptidyl vinyl sulfone which target 
cysteine protease (Thornberry N.A. et al.  1994, Greenbaum D. et al.2000, Wang G. et al. 
2003), fluorophosphonate (FP) group which target serine hydrolases (Liu Y. et al. 1999) and 
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sulfonate ester which target several different classes of enzymes (Thiolase, aldehyde 
dehydrogenase, NAD/NADP-dependent oxidoreductase, epoxide hydrolase, glutathione S-
transferase) (Adam G.C. et al. 2001, 2002a). The second type of reactive unit is based on 
suicide inhibitors and requires enzyme to cleave the substrate to uncover highly active 
nucleophilic group which can eventually react with nearby protein residues. Examples of 
suicide inhibitor probes are p-hydroxymandelic acid derivatives and 2-difluoromethylphenyl 
phosphate targeted to phosphatases (Lo L.C. et al.1996, Betley J.R. et al. 2002, Lo L. et 
al.2002, Zhu Q. et al.2003). 
 
 
1.2.2.2 Linker/recognition unit 
In a typical ABP, the reactive and the tag units have different biological functions 
upon binding to the target enzyme.  The reactive unit typically contains certain chemical 
functionality that is recognized, and subsequently becomes reactive toward the active site of 
the enzyme.  The tag unit on the other hand, is typically made up of either a fluorescent 
molecule (e.g. FITC, Cy3 & Cy5 etc) or an affinity tag (e.g. biotin), which in many cases is 
detrimental to the binding between the probe and the enzyme.  Consequently, it is often 
necessary to have a linker unit, within the ABP, which serves not only to bridge the two 
units together, but also to minimize the overall binding interference of the tag unit toward 
the enzyme.  Additionally, the linker unit in many cases also serves as part of the enzyme-
recognizing unit in facilitating the reactive unit-enzyme binding, as well as defining 
differential specificity of a probe toward different enzymes within the same class.  
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There are generally two types of linker: sequence-specific and nonspecific linkers.  
The first type is rarely used in broad-based ABP, because they are typically made up of 
defined peptide sequence and are highly specific to their targeting enzymes. The nonspecific 
linkers are more commonly used, as they are well-suited for potential large-scale protein 
profiling experiments, which aim to simultaneously target many different enzymes within 
the same class.  These linkers are typically made up of long aliphatic chains of either 
hydrophobic (e.g. alkyl chains) or hydrophilic molecules (e.g. polyethylene glycols, 
polyglycines), which serve to modulate the probes’ activities (e.g. reactivity, solubility etc) 
(Kidd D. et al.  2001).  
 
 
1.2.2.3 Tag unit 
The tag unit is incorporated into an activity-based small molecule probe to facilitate 
sensitive detection, quantitation, isolation and the subsequent identification of enzymes 
upon their labeling by the probe.  Most commonly used tags are: biotin and its derivatives, 
fluorescent dyes, isotopes and others, just to name a few.   
 Biotin is an affinity tag, its interaction with streptavidin is one of the strongest non-
covalent interactions known and can stand a relatively harsh washing condition. (Green 
N.M. et al. 1973, Reznik G.O. et al. 2001)  The biotin tagged-probe labeled protein can be 
isolated, concentrated and purified by streptavadin-agarose bead from the crude cell lysate 
and subsequently identified by MS. This strategy is valuable to detect low abundance 
enzyme. The labeled protein can also be separated by gel based method and visualized by 
commercially available western blot detection kit (Bio-rad website). However, very often 
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endogenously biotinylated proteins and unspecific binding will introduce false positive 
result.  
 When compared to biotin, fluorescent tag offer more advantages. Firstly, fluorescent 
tag can be visualized directly and efficiently by a fluorescence-based scanner. Unlike the 
biotin-streptavidin system mentioned above, it does not require several hours of antibody 
incubation and washing steps and hence are more compatible to high-throughput proteomic 
experiments. Secondly, the versatile choices of fluorescence tags, such as Cy3, rhodamine, 
fluorescein, and so on, makes it possible for multiplexing experiment in which a mixture of 
probes with different fluorescence tags be used to profile different targeted enzyme in the 
same proteome sample or same targeted enzyme from different proteome samples. Thirdly,  
fluorescent tag also offers higher sensitivity and wider dynamic range than biotin tag. For 
example, 0.1 fmol of enzyme can be detected by fluorescence tag labeled probe, which is 
100-fold better than biotin tag labeled probe (Patricelli M.P. et al.  2001).  
 
1.2.2.4 Application of ABP in gel-based proteomics 
ABP can provide valuable information (eg differential enzyme activities) only when 
it is used with other proteomics techniques. Currently, ABP have been successfully 
combined with two existing proteomics platforms, namely gel-based proteomics (Cravatt 
B.F. et al., 2000; Jessani N. et al., 2002; Weihofen A.  et al., 2002) and microarray-based 
technologies (Chen et al., 2003). Due to the nature of this project, the latter will not be 
discussed and only the former will be elaborated. 
 ABP, when combined with 2DE-MS, simultaneously detects changes in the activity 
of many proteins of the same class in the cells, tissues and fluid samples. (Cravatt B.F. et 
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al., 2000). Typically, proteins, which were extracted from cells or tissues, were incubated 
with ABP, and followed by separation by gel-based techniques like sodium dodecyl 
sulphate polyacrylamide gel electrophoresis (SDS-PAGE), and the tag signal of each bands 
were detected by a suitable techniques (e.g. fluorescence imaging or western blots). The 
activities of the probe-labeled enzymes may be profiled and MS was carried out to identify 
the labeled proteins (For overall scheme refer to Figure 3). 
Proteome (extracted cell lysate) 
Incubation with fluorescent ABP 
SDS-PAGE
Fluorescent image 
                           
MS 
Figure 3 Strategy of gel-based activity profiling using ABP 
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An example of a work carried out by Jessani N. et al. (2002) is the profiling of 
serine hydrolases activity of a panel of breast and melanoma cell lines. In this paper, two FP 
probes were used, one was rhodamine- coupled FP probe for easy profiling of serine 
hydrolases activity, and another was biotin coupled FP probe for rapid isolation and 
identification of labeled proteins. By quantitatively comparing the profiling data of different 
cell lines, a serine hydrolase (KIAA1363) was found to be a molecular marker for cancer 
cell invasiveness. This work aptly demonstrated the potential of ABP in enzyme activity 
profiling and their subsequent contribution to the diagnosis and possible treatment for 
cancers. 
 
Another application of enzyme-targeting probes is in the identification of new 
functions in unknown proteins from a proteome.  Because the probe is able to specifically 
label a class, or in some instances a few classes, of enzymes, it could be used to characterize 
previously uncharacterized enzymes in a proteome based on their activity.  An example of 
this type of work is in the identification of a novel signal peptidase by TBL4K probe 
(Weihofen A. et al., 2002).  The authors used the probe to label the detergent-solubilized, 
ER-membrane subproteome, followed by separation on a SDS-PAGE.  They identified a 
42-kD protein, which was labeled by TBL4K probe in the presence of detergents.  Upon 
further analysis by MS, the protein was confirmed to be a previously uncharacterized 
protein.  Consequently, they were able to further classify the protein as a signal peptidase, 




1.3.1 Apoptosis   
Apoptosis, or programmed cell death, is a cell-intrinsic process that is essential for 
animal development and tissue homeostasis. It is needed for the formation of fingers and 
toes of foetus and formation of synapses between neurons in the brain (Jacobson M.D. et 
al., 1997). But in human, both excessive and insufficient apoptosis can lead to severe 
diseases. For example, abnormal up-regulation of apoptosis contributes to 
neurodegenerative like Alzheimer's disease, Parkinson's disease, Huntington's disease and 
amyotrophic lateral (Yuan J. and Yankner B.A., 2000). On the other hand, suppression of 
the apoptotic machinery causes autoimmune diseases and is a hallmark of cancer (Hanahan 
D. and Weinberg R.A., 2000; Thompson C.B. 1995).  
Apoptosis can be triggered by a variety of stimuli, these include cytokines, 
hormones, viruses, and toxins. The initial sign of apoptosis was morphological: dying 
cells exhibit a characteristic pattern of changes, which include cytoplasmic shrinkage, 
active membrane blebbing, chromatin condensation, and, typically, fragmentation into 
membrane-enclosed vesicles (Wyllie A.H. et al., 1980). This visible transformation is 
accompanied by a number of biochemical changes. Changes at the cell surface include 
externalization of phosphatidylserine (Martin S.J. et al., 1995) and other alterations that 
promote recognition by phagocytes (reviewed by Savill J., 1997). Intracellular changes 
include the degradation of chromosomal DNA into high-molecular-weight (Oberhammer 
F. et al., 1993) and oligonucleosomal fragments (Wyllie A.H., 1980), as well as cleavage 
of a specific subset of cellular polypeptides (Kaufmann S.H. 1989; Ucker D.S. et al., 
1992; Lazebnik Y.A. et al., 1993). This cleavage is now known to be accomplished by a 
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specialized family of cysteine-dependent aspartate-directed proteases (Lazebnik Y.A. et 
al., 1994) termed caspases (Alnemri E.S. et al., 1996).  
 
1.3.1.1 Caspases 
The first discovery of the involvement of protease in apoptosis was in nematode 
Caenorhabditis elegans (Yuan J. et al., 1993). The CED-3, a cysteine protease with unusual 
substrate specificity for aspartate residues, soon led to the discovery of its mammalian 
relative (caspases). Since then, a large number of CED-3-related proteases have been 
identified. At least 14 distinct mammalian caspases have been identified, but not all of them 
participate in apoptosis (Shi Y., 2002).  
Caspases are synthesized as proenzymes that are composed of three domains: an N-
terminal prodomain, a large subunit (about 20kDa) and a small subunit (about 10kDa) 
(Earnshaw W.C. et al., 1999). Caspases are generally divided into two groups: the initiators, 
which initiate the apoptosis cascade, and the effector which carry out proteolytic events 
leading directly to cellular breakdown. The initiators are activated by proteolytic cleavage 
and subsequent heterodimerise. Once activated, they trans-activate other caspases (the 
effectors) by proteolytic cleavage. This creates a proteolytic cascade that spreads outwardly 
and destroys key proteins, leading to apoptosis.  
  17
Prodomain Large subunit Small subunit 
Initiator procaspase (caspase-2, -8, -9, -10) 
Active initiator caspase 
(heterotetramer) 
Activate
Executioner procaspase (caspase-3, -6, -7) 
Active executioner caspase 
Caspase substrate 
Apoptosis  
Figure 4 Caspase activation cascade 
1.3.1.2 Serine proteases in apoptosis  
Serine hydrolases, which contain a serine at the active center that participates in the 
formation of an intermediate ester to transiently form an acyl-enzyme complex, represent 
one of the largest and most diverse classes of enzymes in higher eukaryotes, it makes up 
~3% of the predicted Drosophila proteome (Rubin G.M. et al., 2000). Subclasses of serine 
hydrolases include proteases, lipases, esterases, amidases, and transacylases. They play 
important roles in numerous developmental and tissue-specific events in vivo, including 
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inflammation (Clark J.D. et al., 1995), blood coagulation (Kalafatis M. et al, 1997), 
angiogenesis (Mignatti P. et al, 1996), peptide hormone processing (Seidah N.G. et al, 
1997), neural plasticity (Yoshida S. et al, 1999), and T-lymphocyte- mediated cytotoxicity 
(Smyth M.J. et al, 1996). In addition, several diseases are associated with dysfunctions in 
serine proteases and/or their endogenous inhibitory proteins, including emphysema (Kato 
G.J. et al, 1999), hemorrhagic disorders (Kato G.J. et al, 1999), and cancer (Declerck 
Y.A. et al, 1997).  
Compared to caspases, participation of other proteases in apoptosis is less 
understood (Johnson D.E., 2000), and this include serine protease. Involvement of serine 
proteases in apoptosis (Serpases) has been studied mostly by observing whether particular 
apoptotic events can be prevented by the specific inhibitors of these enzymes. In the early 
studies, Gorczyca W. et al (1992) have shown that fragmentation of DNA in HL-60 cells 
treated with DNA topoisomerase inhibitors to induce apoptosis was prevented by 
irreversible inhibitors of serine proteases such as N-tosyl-L-phenylalanine chloromethyl 
ketone (TPCK), diisopropylfluoro-phosphate (DFP), and N-tosyl-L-lysine chloromethyl 
ketone (TLCK), as well as by excess of the substrates N-benzoyl-L-tyrosine ethyl ester 
(BTEE) and N-tosyl-L-argininemethyl ester (TAME). Similarly, Bruno S. et al (1992a, b) 
observed that the same inhibitors and substrates inhibited nuclear fragmentation as well as 
fragmentation of DNA in other cell types, including thymocytes treated with the 
corticosteroid prednisolone. It was also observed that these inhibitors prevented 
destabilization of double-stranded DNA (Hara S. et al., 1996) which during apoptosis 
becomes sensitive to denaturing agents and can be detected as single-stranded DNA (Hotz 
M.A. et al., 1992). These initial observations were confirmed in many subsequent studies 
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and in other cell systems. (Kim R. et al., 2001; Mansat V. el al., 2001; Gong B. et al., 
1999; Komatsu N. et al., 1998) 
One thing to note is, similar to caspases, the activities of many serine hydrolases 
are regulated in a posttranslational manner (e.g., zymogen cleavage for catalytic activation 
(Khan A.R. et al., 1998), inhibitor binding for catalytic inactivation (Whisstock J. et al., 
1998 and Roberts R.M. et al., 1995), indicating that standard, abundance-based genomics 
and proteomics methods may be of limited use for the functional analysis of these 
enzymes. To date, the number of mammalian serine hydrolases identified is impressive, 
with the endogenous functions of many members of this enzyme family remaining 
unknown. Hence, there is a calling needs for alternative methods to study these enzymes. 
One approach for the analysis of serine hydrolase function would be to characterize these 
enzymes collectively, rather than individually, using ABP. 
 
 
1.3 Aim of the project 
 In this project, we aimed to develop methods to profile a subset of a proteome, and it 
is divided into two main parts. In the first part, we aimed to combined DIGE technology and 
ABP to profile differential expression of serine hydrolases in normal and ultra violet (UV)-
induced apoptotic HeLa cells. And in the second part, using another ABP, we aimed to label 
and identify caspases in vivo in apoptotic HeLa cells. 
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1.3.2 Differential expression profiling of serine hydrolases in normal and apoptotic cells 
It has been reported by Liu et al (1999) that a FP, when linked to a small molecule 
reporter group, can serve as a potent and selective probe for simultaneous monitoring of 
all serine hydrolases. This is because majority of the serine hydrolases are irreversibly 
inhibited by FP derivatives like diisopropyl fluorophosphates (Walsh C.T., 1979; 
Creighton T.E., 1993), whereas cysteine, aspartyl, and metallohydrolases are mostly inert 
to such agents. In addition, the reactivity of FPs with serine hydrolases requires that the 
enzymes be in a catalytically active state (Walsh C.T., 1979; Creighton T.E., 1993; 
Pineiro-Sanchez  M.L. et al., 1997), hence making it an ideal ABP. 
 In this part of the project, FP probe tagged with Cy3, Cy5 and biotin (Figure 5, 
Figure 6, Figure 7) were used to profile ONLY serine hydrolases. The probes will be refered 








































Figure 7 Structure of FP-Biotin 
1.3.3 In vivo labeling of caspases in apoptotic HeLa cells 
Currently, most applications of ABP are applied to proteins extracted from cells or 
tissues lysates, (Jessani N. et al., (2002); Weihofen A. et al., 2002) which means that the 
proteins are not in their native cellular environment. Hence, “native” characters of enzymes, 
like endogenous activators/inhibitors effect and enzyme location, may be out of vision. To 
meet the challenge of in situ enzyme activity profiling in a dynamic cellular environment, a 
few ABP have been generated to label proteome in vivo (Greenbaum D. et al., 2002; Speers 
A.E. et al., 2003).  
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 In our laboratory, a fellow colleague (Liau M.L. et al. 2003) had previously reported 
a synthesis of a probe that labels caspases. Liau showed that this probe labels commercially 
available caspases over other non-caspase enzymes in vitro. In the second part of this 
project, we will present an extension of her work. Similar probes were synthesized, but 
instead of using the reported Cy3 as tag unit, fluorescein and biotin were separately used to 
generate two other probes (the probe will be referred to as caspase-fluorescein and caspase-
biotin respectively) (Figure 8 and Figure 9). Using these probes, we aimed to show in vivo 
































Figure 9 Structure of caspase-fluorescein  
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C h a p t e r  2  
MATERIALS AND METHODS 
2.1 Materials 
 All ABP were synthesized by my colleagues from the Department of Chemistry, 
National University of Singapore. Detailed synthesis of FP probe was described by Chen et 
al.(2003), and the synthesis of caspase probe was described by Liau et al. (2003). 
Chymotrypsin were bought from Sigma (St. Louis, Mo) 
 
2.2 GatewayTM Technology 
2.2.1 Polymerase Chain Reaction (PCR) amplification of a known serine hydrolase gene  
 A gene, subtilisin-like protease III (YSP3) from yeast ex-clone (Invitrogen, Ca) was 
extracted using Qiaprep Miniprep system (Qiagen). PCR of YSP3 was performed using the 
forward primer BP-Exclone_F (5’- GGG GAC AAG TTT GTA CAA AAA AGC AGG 
CTC CGT GGA ATT CCA GCT GAC CAC CAT G –3’), and the reverse primer BP-
Exclone_R (5’- GGG GAC CAC TTT GTA CAA GAA AGC TGG GTC GAT CCC 
CGG GAA TTG CCA TG –3’) which contained both the attB sites (in bold) and the ex-
clone specific sequence (underlined). 50 µl reaction was performed using 100ng of YSP3 
DNA, 25 pmole of each primers, Deep Vent polymerase buffer, 0.2mM of each dNTPs, 1 
units of Deep Vent Polymerase and H2O. Amplification was carried out using Peltier 
thermal cycler at 94oC for 4 mins, followed by 30 cycles of 94oC for 45 sec, 53oC for 45 
sec, 72oC for 2 min, and a final extension at 72oC for  5mins.  
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Precipitation of the PCR products was done by adding 5 µl of 3 M Na Acetate pH 5.2, 100 
µl of cold ethanol (100 %), and placed in -20oC for 10 hours. Precipitated DNA was 
centrifuged (4000 rpm, 4oC for 1 hour) and pellet washed with 100 µl of 70 % ethanol. The 
pellet was dried by placing on warm heat block, and 15 µl of H2O was used to re-suspend 
the DNA.  
 
2.2.2 BP reaction 
 The PCR products were used to perform 1/4 BP reaction with the pDONR201. The 
BP reaction was performed by adding 100 fmol of the PCR products, 300 ng of supercoiled 
pDONR201, 1 µl of 5x BP Clonase reaction buffer (Invitrogen), 1 µl BP Clonase mix  
(Invitrogen) and topping up with TE Buffer pH 8.0 (10 mM Tris-HCl, 1 mM EDTA, pH 
8.0) to 6.25 µl. The reaction mix was incubated at 25oC for 1 hour, before inactivation by 
adding 1 µg proteinase K (37 oC for 10 mins). Transformation was carried out by adding all 
of the BP reaction mix to 100 µl of competent Top10 cells [(F-, mcrA, ∆(mrr-hsdRMS-
mcrBC), φ80lacZ∆M15 ∆lacX74, deoR, recA1, araD139 ∆(ara-leu)7697, galK, 
rpsL(StrR), endA1, nupG],  using heat shock method. Cells were plated onto Luria-Bertoni 
(LB) Km Agar (supplemented with 50µg/ml Kanamycin). Colonies from the plates were 
picked and inoculated in 5 ml LB Km Broth. Plasmids were purified using Qiaprep 
Miniprep system (Qiagen) and ran on 1.2 % agarose gel. PCR analysis was carried out to 
verify the present of the insert in the Entry clone using attB1_F (5’- ACA AGT TTG TAC 
AAA AAA GCA GGC T -3’) and attB2_R primers (5’- ACC ACT TTG TAC AAG AAA 
GCT GGG T -3’), which contained complementary sequences to the recombination sites. 
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2.2.3 LR reaction 
The correct clones were selected for 1/8 LR reaction (refer section 2.6). The LR 
reaction was performed by adding 37.5 ng of supercoiled Entry clone (genes of interest in 
pDONR), 37.5 ng of linearized Destination vector (pDEST17, pEGFP_DEST17 or 
pSTA_DEST17),  0.5 µl of 5x LR Clonase reaction buffer (Invitrogen), 0.5 µl LR Clonase 
mix (Invitrogen) and topping up with TE Buffer pH 8.0 to 3.12 µl. The reaction mix was 
incubated at 25oC for 1 hour, before inactivation by adding 0.5 µg proteinase K (37 oC for 
10 mins). Transformation was carried out by adding all of the LR reaction mix to 100 µl of 
competent Top10 cells, using heat shock method. Cells were plated onto LB Amp Agar 
(supplemented with 100µg/ml Ampicillin). Colonies from the plates were picked and 
inoculated in 5 ml LB Amp Broth. Plasmids were purified using Miniprep and ran on 1.2% 
agarose gel to check for correct size. PCR analysis was carried out to verify the present of 
the insert using attB1_F and attB2_R primers which contained complementary sequences to 
the recombination sites. Crude miniprep DNA screened by analytic PCR using attB1_F and 
attB2_R to confirm the authenticity of the clones.  
 
2.2.4 Transformation and induction of protein expression in BL21 (arabinose-induced) (AI) 
Correct clones identified from LR reaction contained gene of interest inserted within 
the recombination site. 1 µl of the plasmid was used to transform BL21 AI (Invitrogen) 
using the heat shock method. 350 µl of the culture was plated on LB Amp Agar, with 
addition of 3.5 µl of 20% Arabinose. One colony from the plate was picked to prepare 5 ml 
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seed culture in LB Amp. 1 ml of the seed culture was used to inoculate 50 ml of LB Amp 
and culture incubated at 37 oC 280 rpm. At 0.4 OD600, 500 µl of 20 % Arabinose was added 
to induce protein expression from T7 promoter, and will be called “induced cell culture”. In 
another flask of culture, no arabinose was added, and will be called “non-induced cell 
culture”. The culture was allowed to incubate for additional 4 hours after the induction. 
Cells were harvested by centrifugation at 4000 rpm, 4 oC for 10 mins.  
 
2.4.4 Sequencing confirmation of clones 
Sequencing was performed using the ABI PRISM BigDye Terminator v3.0 
Sequencing Kit (Applied Biosystem). 1/2 Reaction sequencing mix (20 µl) was prepared by 
mixing 4 µl Ready reaction mix, 2 µl 5x Sequence Buffer, 3.2 µl of (1 pmole/µl) Primers, 
200-500 ng of BL21 (AI) plasmid DNA and H2O. BP-Exclone_F was used as primers. 
Reaction was carried out in the Peltier thermal cycler at 96 oC for 30 sec, 50 oC for 15 sec, 
and 60 oC for 4 min (25 cycles). The extension products were purified by adding 80 µl of 
ethanol/sodium acetate solution (3.0 µl of 3 M sodium acetate NaOAc pH 4.6, 62.5 µl of 
non-denatured 95 % ethanol EtOH, and 14.5 µl of H2O), and tubes allowed to stand at room 
temperature for 15 minutes to precipitate the extension DNA. This was followed by 
centrifugation (15000 rpm for 20 mins) to pellet the DNA. Washing was performed with 70 
% EtOH, and the precipitant dried and stored in -20 oC. Samples were sequenced using the 
ABI Prism 3100 sequencer (Applied Biosystem) at the Department of Biological 
Sciences, DNA Sequencing Laboratory (DSL), National University of Singapore. 
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2.3 Preparation of bacterial and yeast cell lysate 
Equal volume of ice-cold lysis buffer (5 mM Tris-HCl (pH 8.8) and 0.1 % Triton-X)
 and acid washed glass beads (Sigma, 425-600 microns) were added to the cell pellet, and 
the tube was placed in a mixer mill (Retsch, Haan, Germany) for 3 times of 6 minutes at 30 
beat/sec at 4 oC. Supernatants (protein sample) were collected after ultracentrifugation at 75 
000 rpm for 1 h at 4 oC.  
 
2.4 Estimation of protein concentration 
Concentration of the protein samples were estimated using Bradford protein assay 
(Bio-rad, Richmond, Calif.) with standard protocols recommended by vendor. (Bradford 
M., 1976)  
 
2.5 In vitro labeling 
Probes (fluorescent or biotin-tagged) were added to protein samples to a final 
concentration of 2 µM, labeling was carried out for 1 h at 4oC. (Chen G.Y.J. et al., 2003) 
Lysate labeled with fluorescent probe were proceed with SDS-PAGE while the lysate 
labeled biotin-tagged probe underwent affinity purification. 
 
2.6 Affinity purification 
 The cell lysate was incubated with Streptavidin MagneSphere Paramagnetic 
Particles (Promega, MA) for 1 h. The resin was washed with 1% SDS and bound proteins 
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were eluted by boiling for 30 min in the same buffer. The supernatant was kept for SDS-
PAGE or 2D-GE.  
2.7 SDS-PAGE 
Reactions were quenched with one volume of standard 2 X SDS-PAGE loading 
buffer, followed by heating the samples at 90oC for 5 min before analysis on 12 % or 15% 
SDS-PAGE. (Chen Y.J.G. et al., 2003) 
 
2.8 2D DIGE and imaging 
Unless otherwise indicated, all 2D experiments were performed on an Ettan 
IPGphor. isoelectric focusing and Ettan DALT gel system (Amersham, Cleveland, OH, 
USA) using standard protocols recommended by the same vendor (Ettan DIGE User 
Manual, Amersham). Fluoresecntly labeled sample or affinity purified sample in the 
rehydration buffer were applied to the immobilized pH gradient strip (pH 4–7, 18 cm; 
Amersham, USA), passively rehydrated for 1 h, followed by 12 h of active rehydration 
(20 oC, 50 V). The total voltage-hour in isoelectric focusing (IEF) was 32 kVh. After IEF, 
the strips were equilibrated in equilibration buffer 1 (6 M urea, 2% SDS, 0.375 M Tris 
(pH 8.8), 20 % glycerol, 130 mM dithiothreitol; 15 min), then in equilibration buffer 2 (6 
M urea, 2 % SDS, 0.375 M Tris (pH 8.8), 20% glycerol, 135 mM iodoacetamide; 15 min), 
before being applied directly to a 12% SDS-PAGE gel. The SDS electrophoresis was run 
first at 2.5 W/gel (for 30 min), then 17 W/gel until the dye front was 1 mm from the 
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bottom of the gel. Each gel was repeated at least once. Similar results were obtained. Gel 
images were collected using a TyphoonTM 9200 (Amersham, USA) fluorescence gel 
scanner. A 580-nm band-pass filter, which transmits light between 565 nm and 595 nm 
and has a transmission peak centered at 580 nm, was used for collection of Cy3 images. A 
670-nm band-pass filter, which transmits lights between 655 nm and 685 nm and has a 
transmission peak centered at 670 nm, was used for collection of Cy5 images. Gels were 
either silver- stained using methods described previously (Blum H. et al., 1987) or by 
using SYPRO ruby. 
 
2.9 SYPRO ruby protein stain 
After electrophoresis, gels were fixed in 40 % methanol, 10 % acetic acid for at 
least 1 h before incubation with SYPRO Ruby stain for 90 min with continuous, gentle 
agitation. The gels were washed in 10 % methanol, 6 % acetic acid for 1 h and followed 
by imaging with the fluorescence gel scanner. The excitation wavelengths are 300 nm and 
480 nm and the emission wavelength is 618 nm. So, a 610-nm band-pass filter, was used 
for collection of SYPRO ruby images.  
 
2.10 Western blot 
The labeled proteins were separated in SDS–PAGE. Polyvinylidene difluoride 
(PVDF) membrane (pre wetted with methanol)(Biorad) and filter papers were soaked in 200 
ml of transfer buffer (14.4 g Glycine, 3 g Tris Base, 1 g SDS, 200 ml methanol in 1 litre 
preparation) for 10 mins. Using the Hoefer Semi Phor system - semi-dry transfer unit (45 
mA, 50 V for 30 mins), SDS-PAGE gel was electroblotted onto the PVDF membrane. 
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Membrane was blocked by soaking in 5% non-fat dry milk in PBST (0.1 % Tween 20 in 
phosphate buffer saline pH 7.4) for 1 h, before incubating with HRP-conjugated anti-biotin 
antibody (New England Biolab) (1:1000 dilution in milk PBST) followed by a secondary 
antibody (if required). Detection of the antibody binding was carried out using the Enhanced 
ChemiLuminescent (ECL) method (Towbin and Gordon) (2 ml Solution A and 15 µl 
Solution B, with 1 min incubation) (Amersham Pharmacia Biotech). Membrane was 
exposed to Biomax MR Film (Kodak) for 20 sec and 30 mins respectively, films were 
developed in the dark.  
 
2.11 Elution of whole protein from SDS-PAGE gel 
Elution was carried out as describe by Cohen S.L. et al (1997). 
 
2.12 In-gel digestion of proteins 
In-gel digestion was carried out essentially as previously described by Nawrocki 
A. et al. (1998). Protein spots were excised from the gels, washed in 50 mM 
NH4HCO3/acetonitrile (50/50 % v/v) three times and dried by vacuum centrifugation. 
Modified porcine trypsin (12.5 ng/mL sequencing grade; Promega, Madison, WI, USA) in 
digestion buffer (50 mM NH4HCO3) was added to the dried gel pieces and incubated on 
ice for 30 min for re-swelling. After removing the supernatant, 50 mM NH4HCO3 was 
added just covering the gel pieces and the digestion was continued at 37oC for 12 h. The 
peptide mixture was extracted, vacuum-dried and redissolved in 2 µL of 5% formic acid 
prior to mass analysis. 
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2.13 MALDI-TOF mass spectrometry 
A matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass 
spectrometer (Voyager-DE STRTM; Applied Biosystems, USA) was used to obtain the 
corresponding mass spectra of digested proteins by the delayed-extraction reflection 
mode. The MALDI-TOF MS data was used for protein identification by searching NCBI 
database using MascotTM search engine at http://www.matrixscience.com. 
 
2.14 Preparation of apoptotic cells 
2.14.1 Strains and culture condition 
The HeLa cell line was a gift from Developmental Biology Laboratory of National 
University of Singapore. The cells were cultivated in Dulbecco's modified Eagle's medium 
(DMEM; Sigma) containing 10% fetal calf serum (FCS, Gibco BRL) and 100 units/ml 
Penicillin G and 100 µg/ml Streptomycin Sulfate( Irvine Scientific, Santa Ana, CA) at 37 
oC in a 5% CO2 atmosphere.  
 
2.14.2 Apoptosis induction of HeLa cells by UV irradiation 
HeLa cells were induced to be apoptotic by exposing to UVB as carried out by 
Isoherranen K. et al., 1999, with slight adjustment to the time of irradiation. Briefly, before 
UVB exposure, the cells were washed twice with phosphate-buffered saline (PBS), which 
was also added to the cell cultures during the time of UV irradiation. The cells were placed 
on Hoefer™ MacroVue™ UV/Visible Transilluminators (Amersham, USA) for 10 minutes. 
The UV spectrum is 302 nm and its average surface intensity is 7000 µW/cm2 (in the low 
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intensity mode). After UVB exposure, fresh culture medium was added to the dishes 
Control cells were subjected to identical procedure but without UV exposure. 
 
2.14.3 In vivo labeling 
Caspase-fluorescein probe was added to culture media (final concentration of 25 
µM) 12 h after UVB irradiation, unless otherwise stated. Labeling was carried for one and 
a half hour, and after which the cells were harvested.  
 
2.14.4 Evaluation of apoptosis  
Cell morphology was examined using fluorescence microscopy and cells with 
characteristic shrinking and membrane blebbing were scored as apoptotic. Fluorescent 
images were recorded with a AxioSkop 40 fluorescent microscope (Carl Zeiss, Germany) 
equipped with a cooled CCD camera (AxioCam, Zeiss) using a 63 X objective. 
 
2.14.5 Preparation of HeLa cell extract 
Before the cells were harvested, they were washed twice with 1 X PBS. 0.2 mL of 
ice-cold lysis buffer was added to each of 150 mm dish of adherent HeLa cells. Cells were 
scraped off the dishes with a plastic cell scraper that has been cooled in ice-cold distilled 
water. The cell suspension was transferred into a centrifuge tube. Equal volume of acid 
washed glass beads (Sigma, 425-600 microns) were added, and the tube was placed in a 
mixer mill (Retsch, Haan, Germany) for 3 times of 6 min at 30 beat/sec at 4oC. Supernatants 
(protein sample) were collected after ultracentrifugation at 75 000 rpm for 1 h at 4oC. For 
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lysate labeled with caspase-fluorescein probe, SDS-PAGE or 2D-GE were carried out. For 
lysate labeled with caspase-biotin probe, affinity purification was carried out, and followed 
by 2D-GE and identification of proteins by MS. 
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3.1 Labeling and identifying of a commercially available serine hydrolase 
Labeling with FP-Cy5 was first tested using chymotrypsin, a well-known serine 
hydrolase. The labeled protein was electrophoresed on a SDS-PAGE (Figure 10), followed 
by excision of the fluorescent bands. One of the bands was eluted directly from the gel, 
without trypsin digestion; while another band was subjected to trypsin digestion to produce 
small fragments of peptides, followed by elution from the gel. Both eluted protein/peptides 
were analysed by MS.  
MS results showed that the undigested labeled chymotrypsin gave similar molecular 
weight as unlabeled chymotrypsin (≈ 25kDa) (Figure 11). And for the digested protein 
sample, it was successfully identified to be a chymotrypsin in a database search, with 




Figure 10 SDS-PAGE of FP-Cy5-labeled chymotrypsin 
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Figure 12 MALDI-TOF-MS spectrum of digested chymotrypsin 
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1   cgvpaiqpvl sglsrivnge eavpgswpwq vslqdktgfh fcggslinen wvvtaahcgv 
61  ttsdvvvage fdqgssseki qklki  akvfk nskynsltin nditllklst aasfs  qtvsa
121 vclpsasddf aagttcvttg wgltrytnan tpdrlqqasl pllsntnckk ywgtkikdam 
181 icagasgvss cmgdsggplv ckkngawtlv givswgsstc ststpgvyar vtalvnwvqq 
241 tlaan 
 
Figure 13 Chymotrypsin matched peptide alignment sequences (underlined and in bold) 
 
3.2 Optimization of sample preparation steps 
 In most protein extraction steps, denaturing and chaotropic compounds like urea, 
thiourea or guanidine hydrochloride were used. As mentioned, since ABP labels only active 
proteins, normal lysis buffer, which denatures proteins, will not be applicable to our usage. 
Therefore, experiments are conducted to optimized protein extraction methods. An ideal 
lysis buffer for our experiment will be those that do not denature proteins, but yet maintains 
the solubilisation and activities of the proteins. In addition, the lysis buffer must not have 
high salt content, because such condition will affect subsequent isoelectric focusing. Using a 
lysis buffer described by Liu Y.S. et al. (1999) in similar ABP labeling experiment,  by 
varying its concentration with two different common types of cell membrane shearing 
methods (bead-beating and sonication), we have shown that optimal lysis was attained by 
using 5 mM Tris (pH 8.8) and 0.1 % Triton with 3 times of 6 min of bead beating. As for 
the labeling condition, the  probe was added to the lysate AFTER ultracentrifugation, and 




                   
Figure 14 Optimization of lysis and labeling condition.(a) Lane 1: 50 mM Tris (pH 8.8), 
0.1 % Triton; Lane 2: 50 mM Tris (pH 8.8), 0.1% Triton, 2 µM FP-Cy5; Lane 3: 5 mM 
Tris (pH 8.8), 0.1 % Triton; Lane 4: 5 mM Tris (pH 8.8), 0.1 % Triton, 2 µM FP-Cy5; 
Lane 5: water, 2 µM FP-Cy5. For lane 1 and 3, labeling was done after 
ultracentrifugation of lysates and not during lysis step (b) Optimization of membrane 
breaking method. Lane 1: 3 X 30 s sonication; Lane 2: 6 X 30 s sonication; Lane 3: 9 X 
30 s sonication; Lane 4: 3 X 6 min bead beating; Lane 5: 6 X 6 min bead beating; Lane 
6: 3 X 30 s sonication and 3 X 6 min bead beating. There was a 5 min interval between 
each sonication or beating. 
 
(a) (b) 
5 1 2 3 4 5 6 1 2 3 4 
Figure 15 2D fluorescent gel of FP-Cy5 labeled yeast proteins. On the right is a normal 
one dimensional (1D) gel electrophoresis of the same labeled sample. A thick band in the 
1D sample was made up of 2 protein spots in the 2D-GE (boxed). 
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The yeast lysate, which was extracted using the optimized lysis method, was 
electrophoresed on a 2D gel. Yeast proteins labeled with FP-Cy5 were shown in Figure 15 
and Figure 16(a). In Figure 15, a labeled yeast sample (without going through IEF) was ran 
along side with a 2D sample. 
The gel in Figure 16 (a) was further stained with SYPRO Ruby protein gel stain 
(Figure 16(b), (c)). SYPRO Ruby protein gel stain is a luminescent metal chelate stain 
comprised of ruthenium as part of an organic complex. It allows sensitive fluorescence 
detection of proteins in SDS-polyacrylamide gels. Since it has a non-overlapping spectra 
(excitation wavelengths are 300 nm and 480 nm and the emission wavelength is 618 nm) 
with Cy 5 (excitation wavelengths are 625-650 nm and the emission wavelength is 670 
nm), the gel were viewed separately at different wavelength. Cy5 (green) and SYPRO ruby 
(red) images were overlapped using ImageQuant™ software (Figure 16 (b), (c)). 








          
(c) 
 
  Figure 16 (a) 2D gel showing fluorescent spots which were yeast proteins labeled with 
FP-Cy5 (green). (b) A SYPRO Ruby (red) stained gel, and it was an overlapped with Cy5 
gel image.  M is the molecular marker. 
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3.3 Identification of serine hydrolases in yeast proteome 
 
Several attempts were made to identify excised fluorescent spots from 2D gel, but due 
to the low concentration of the labeled proteins, MALDI-TOF MS were not able to detect 
any mass spectra. This problem was circumvented by using another probe, FP-biotin. By 
exploiting the biotin-avidin system, the proteins that have been labeled by biotinylated 
probe was purified or enriched by affinity purification using Streptavidin MagneSphere 
Paramagnetic Particles.  
Using this method, more yeast lysate were used, and after several stringent washings, 
unlabeled proteins were washed away, leaving only the labeled proteins being bound to 
streptavidin particles. Consequently, a higher concentration of the labeled proteins was 
loaded into the 2D gel and was detected by silver staining (Figure 17 (a)). A control (Figure 
19 (b)), yeast lysate with no labeling with FP-biotin, was ran in parallel during affinity 
purification. The two gels were compared to confirm that all the spots obtained in Figure 19 
(a) were labeled and enriched by FP-biotin and not due to proteins which bind 
unspecifically to the streptavidin beads. 
The spots were excised, tryptic digested and followed by MALDI-TOF analysis. 
Identities of the spots were shown in 
Table 1 and mass spectra and peptide sequence alignments of these proteins were 
shown in Appendix.  
A database search confirmed that one of the spot identified, subtilisin-like 
protease, is a serine hydrolase (Siezen R.J. et al, 1997). Another protein identified is 
 
vesicular transport protein, sec17, which is a peripheral membrane protein that is involved 
in the yeast secretory pathway (Griff I.C. et al., 1992). Although no known report was found 
to indicate this protein is a serine hydrolase, but another component of this pathway, sec11 
has been classified to be a serine peptidase in peptidase family S26. A protein sequence 
alignment between sec17 and sec11 showed a moderate homology of 12.6 % (Figure 18). 















2D gel showing FP-biotin labeled proteins(a) from yeast lysate; (b) is a 
 no FP-biotin labeling. Affinity purification was carried out with both 
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Spot number protein name MR pI 
2 Subtilisin-like protease III 52 5.2 
6,8 Vesicular Transport Protein Sec17 33 5 
10 Hypothetical 61.1 kDa protein in YPT52- 
DBP7 intergenic region 
 61 6.5 
 




Figure 18  Protein sequence alignment of sec17 and sec11 using ClustalW 
(http://www.ebi.ac.uk/clustalw/)
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3.4 Differential profiling of serine hydrolases  
3.4.1 Proof of concept  
In this proof of concept experiment, subtilisin-like protease III (YSP3), a known 
serine hydrolase (Siezen R.J. et al, 1997), which was labeled and identified in our previous 
experiment, was chosen as the protein of interest. YSP3 gene was taken from a yeast ex-
clone (Invitrogen), and was cloned into GatewayTM system. Briefly, the gene was cloned 
into a donor vector (Figure 19) then into a bacterial destination vectors, and the resulting 
expression clone was subsequently transform into a bacterial expression host BL 21(AI) 
for induced expression of the protein of interest.  
Two evidences confirmed the presence of the YSP3 gene in the bacterial expression 
host. First, PCR amplification of YSP3 (Figure 20) using attB1_F and attB2_R primers 
showed a band at around 1400 bp which is the size of the gene of our interest (1437 bp). 
Second, a sequencing experiment using isolated plasmid DNA from BL 21(AI) and primer 
(BP-Exclone_F) which contained both the attB sites and the ex-clone specific sequence, was 
further carried out. From the sequencing results (Figure 21), it showed that the sequenced 
sample showed good sequence alignment (94 %) with the YSP3 sequence found in the 
database, hence confirming that YSP3 has been successfully cloned into the bacterial 
expression host. 
To induce protein over-expression from T7 promoter of the destination vector, 
arabinose was added into the BL 21(AI) bacteria culture. The induced lysate was labeled 
with FP-Cy5 probe and a bright fluorescent band (52 kD) was observed on an SDS gel 
shown in  
 
Figure 22. Lysates from BL21 (AI) which was not transformed by YSP3-containing 
expression clone and lysates from BL21 (AI) which was transformed by YSP3-containing 
expression clone, but not induced by arabinose were used as controls. YSP3 band at 52 kD 
















 19 : The BP (first step) and LR (second step) Reaction of GatewayTM system 




1437 bp 1000 bp 
 20 PCR analysis using attB1_F and attB2_R primers was carried out to verify the 
ce of the gene, YSP3, in bacteria expression host BL21 (AI). 
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ORF:YOR003W YSP3 SGDID:S0005529, Chr XV from 331455-332891 
Score = 3577 (542.7 bits), Expect = 6.7e-158, P = 6.7e-158 
 Identities = 755/795 (94%), Positives = 755/795 (94%), Strand = Plus / Plus 
 
Figure 21 Basepair alignment of the sequencing results showed good sequence alignment 





Endogenous serine hydrolase   
YSP3 (52 kD) 
1 2 3  
Figure 22 Over-expression of YSP3 by arabinose induction in bacteria expression host 
BL21 (AI). M is the molecular marker. The enlarged gel image showed FP-Cy5 labeled- 
lysate from: BL21 (AI) which was NOT transformed by YSP3-containing expression 
clone (Lane 1); BL21 (AI) which was transformed by YSP3-containing expression clone, 
but NOT induced by arabinose (Lane2); BL21 (AI) which was transformed by YSP3-
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Figure 23 DIGE of induced and non-induced transformed bacterial lysates. The former 
was labeled with FP-Cy3 while the latter was labeled with FP-Cy5 probes. Orange spots 
are endogenous serine hydrolases similarly expressed in both lysates and the green, 
circled spot are over-expressed YSP3. 
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In the proof of concept experiment, two bacterial lysates, whose protein expressions 
were induced and non-induced by arabinose, were differentially labeled with FP-Cy3 and 
FP-Cy5 respectively. The two samples were quenched, mixed and co-electrophoresed in a 
single gel. The gel was viewed separately at different wavelength. Spots of serine 
hydrolases in the induced lysate were observed to be green on a fluorescent 2D gel image; 
while in the non-induced lysate, spots of serine hydrolases were observed to be red. When 
the two gel images were overlapped using ImageQuant™ software, orange and green spots 
were observed (Figure 23). Orange spots represented serine hydrolases that were similarly 
expressed in the two lysates, while the green spot represent serine hydrolase that were over-
expressed in the induced lysate. The green spot was confirmed to be our protein of interest 
(YSP3) by its correct mass and pI value (52 kD and pI= 5.2).  
 
3.4.2 Differential profiling of serine hydrolases in normal and apoptotic HeLa cells 
Till now, serine hydrolases that were involved in apoptosis were not well studied. In 
this experiment, using the optimised step of DIGE and ABP, serine hydrolases that 
expressed differentially in apoptotic HeLa cells were quantified. HeLa cells were first 
induced to be apoptotic by exposing the cells to UVB (Isoherranen K. et al., 1999). 
Characteristic morphology of apoptotic cells ( ), which include cytoplasmic 
shrinkage, active membrane blebbing and chromatin condensation (Wyllie A.H. et al., 
1980), were observed in the HeLa cells 12 hours after UV-irradiation.   
Figure 24
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Normal and apoptotic cells were separately lysed, purified and labeled with FP-Cy 
5 and FP-Cy3 respectively. In a DIGE 2D gel, serine hydrolases in normal cells are 
displayed as red spots while those in apoptotic cells are green. In an overlapped gel image 
(Figure 25), majority of the serine hydrolases were down-regulated in apoptotic cells, this 
is evident in the greater number of reddish spots to green spots. In Figure 25, an obvious 
over-expressed serine hydrolase (circled) in apoptotic cells was observed.  
Using the same strategy as was carried out to isolated yeast serine hydrolases, FP-
biotin can be used instead, to identify serine hydrolases which have been over- or under-




      
(a) (b)  
Figure 24 Normal (a) and apoptotic (b) HeLa cells 
 
 
Figure 25 DIGE of normal and apoptotic cell lysates. The former was labeled with FP-
Cy5 (red) while the latter was labeled with FP-Cy3 (green) probes. The circled spots are 
evidently over expressed in apoptotic cells 
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3.5 In vivo labeling of caspases  
Until this point, all ABP labeling was carried out in vitro, which is after the proteins 
have been extracted from the cells. To meet the challenge of in situ enzyme activity 
profiling in a dynamic cellular environment, two other probes, caspase-fluorescein and 
caspase-biotin were synthesized and their feasibility of in vivo labeling were tested. 
In an experiment to show that caspase-fluorescein indeed enters the cell and binds to 
targeting enzymes, two separate culture plates of HeLa cells were labeled in vivo with 
caspase-fluorescein and fluorescein dye (without the reactive unit and linker). Figure 26 
showed fluorescent images of both plates of HeLa cells after repeated similar number of 
washings to remove excess dye/probe. Figure 26 (a) were cells labeled with caspase-
fluorescein probe, which were highly fluorescent when compared to Figure 26 (b), and no 
leakage of the fluorescent dye to the medium was observed. In Figure 26 (b), cells which 
were incubated with fluorescein dye can hardly be seen, this is due to the leakage of the 
fluorescent dye from the cells to the medium which was subsequently washed off after 
repeated washes. HeLa cells were induced to be apoptotic by UVB irradiation, caspase-
fluorescein were added to the media after 12 hours, when the cells showed hallmark 
apoptosis characteristic (Figure 27 (b)). Labeling was carried out for one and a half hour, 
and followed by a few washing steps to remove excess/unbound probes. Some cells were 
observed under a fluorescent microscope as shown in Figure 27, while the rest were 
harvested, lysed and electrophoresed on a 2D gel (Figure 28). Spots pattern were drastically 
different between normal (Figure 28 (a)) and apoptotic labeled- samples (Figure 28(b)). 
This prompted us to label the apoptotic cells at different time point after they were induced 
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by UVB irradiation. Indeed, the labeled- targeted proteins are upregulated (Figure 29) as the 





            
                






Figure 27 Normal (a, b) and apoptotic (c, d) (12 hours after UV irradiation) HeLa cells 






Figure 28 Fluorescent gel images of caspase-fluorescein labeled normal (a) and apoptotic 




Figure 29 Caspase-fluorescein labeling of apoptotic HeLa cells at different time point 
after UVB-irradiation: (a) 0 hour (labeling was carried out immediately after UVB-
irradiation), (b)1 hour,  (c)3 hour, (d) 6 hour. The 3 spots in the box showed obvious 
expression changes during different time point. 
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To identify the proteins labeled by caspase-fluorescein, caspase-biotin probe was 
similarly synthesized to affinity purify the targeted proteins. In vivo labeling of apoptotic 
HeLa cells using caspase-biotin followed by affinity purification by streptavidin beads, 
detect similar set of proteins as caspase-fluorescein (Figure 30). Although as expected, 
biotin-avidin system is not as sensitive as the fluorescent mode of detection, some bands 
were missing when detected by caspase-biotin, but this probe was used to enrich and 
identify targeted proteins in a large scale of apoptotic HeLa cells.  
In a preliminary experiment, a spot was excised from a 2D gel of caspase-biotin 
purified apoptotic cells lysate. Caspase-8 was detected in this initial round of experiment. Its 
mass spectra were shown in Figure 31 and its matched peptide alignment sequences was 
shown in Figure 32. 
(b) (a) 
 













































Figure 32 Caspase-8 matched peptide alignment sequences (underlined and in bold) 
 
 
In a separate experiment where less stringent washes (PBS) and mild elution (6 M 
urea and 4% CHAPS, without boiling) methods were used in the affinity purification step, 
caspase-biotin labeled 2D gel spot patterns were compared with unlabeled lysate (Figure 
33). Majority of the spots were present in both gels. This confirmed our speculation that 
majority of the spots are proteins which bind non-specifically to the streptavidin beads due 
to insufficient washing steps. Meanwhile, a few additional spots were found to be present 
ONLY in labeled lysate gel and not in unlabeled lysate gel. Spots identities of these proteins 
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Spot number protein name MW pI 
1, 2, 4 Glyceraldehyde 3-phosphate dehydrogenase 36 8.5 
3 Fructose-bisphosphate aldolase A 39 8.3 
6 GTP-binding nuclear protein RAN 24 7 
8 Peptidyl-prolyl cis-trans isomerase A 18 7.8 
11, 12 Alpha enolase 50 7 
22 Actin, beta 41 5.5 
23 Proteasome activator complex subunit 3 31 5.8 
24,25 T-cell receptor beta chain C region 34 6.1 
 
Table 2 Proteins (in Figure 33), which were found only in caspase-biotin labeled Hela 




C h a p t e r  4  
DISCUSSION 
Recent development of ABP has addressed the functional shortcoming of other 
proteomic methods (eg, 2D-GE-MS, liquid chromatography (LC)-MS/MS, isotope-coded 
affinity tag (ICAT) (Cravatt B.F. et al., 2000), and has proven itself in several examples 
(Cravatt B.F. et al., 2000; Jessani N. et al., 2002; Weihofen A. et al., 2002) to be an ideal 
functional proteomics strategy. In this project, we have combined this new technology with 
DIGE, and have successfully developed a method to differentially profile a subset of a 
proteome. In addition, we also tested the feasibility of two probes that labels caspases in 
vivo. 
4.1 Labeling and identification of a commercially available serine hydrolase  
To start, a known serine hydrolase, chymotrypsin, was labeled with FP-Cy5, 
followed by conventional protein identification steps (trypsin digest, MS, database search). 
Chymotrypsin was correctly identified from a database search (Figure 13). In a similar 
experiment in which FP-Cy5 labeled chymotrypsin was eluted directly from the gel, without 
going through trypsin digestion, mass spectrum (Figure 11) showed that when compared to 
unlabeled chymotrypsin (25 kD), the weight of the labeled chymotrypsin (25.3 kD) did not 
change drastically . These two experiments showed that despite the addition of the ABP, 
proteins can still be identified via conventional protein identification and that MS results are 
not affected by the fluorochrome (Cy5) which was used to label the proteins of interest.  
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4.2 Optimization of sample preparation step 
After confirming that the commercially available serine hydrolase can be labeled 
and identified by normal 2D-GE-MS strategy, we went on to identify serine hydrolases in 
the yeast proteome. An optimal sample preparation step is very crucial for good 2D-GE 
results. As mentioned, ABP labels only active proteins and this has been reported by Liu et 
al. (1999) that heat-denatured proteins were not labeled by FP-biotin. Hence, normal lysis 
buffer which contain high concentration of chaotrope like 8 M of urea, which unfold most 
proteins to their fully random conformation, is not appropriate for our usage. In addition, 
salt concentration in the lysis buffer must not exceed 10 mM, because it will affect 
subsequent IEF and cause horizontal streaking in 2D gel (Amersham Bioscience’s 2-D 
manual). Liu et al. (1999) has reported the use of 50 mM Tris HCl (pH 8) and 0.32 M 
sucrose for lysis of rat tissue for ABP labeling of which the sample was subsequently ran on 
a SDS-PAGE. Hence, taken together, 50 mM Tris HCl (pH 8) and 5 mM Tris HCl (pH 8) (a 
lower salt concentration) were tested as the main component of our lysis buffer. In addition, 
0.1 % Triton X-100 was added to both lysis buffer to ensure sample solubilization and to 
prevent aggregation through hydrophobic interactions (Klose J., 1975).  
Other than an appropriate lysis buffer, to fully analyse all intracellular proteins, the 
cells must be fully disrupted, hence the choice of the disruption method is also crucial. Two 
common vigorous lysis method were tested namely sonication and bead-beating. After 
which, all samples underwent purification by ultracentrifugation to remove all particulate 
material. 
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Figure 14 showed that using lysis buffer with 5 mM Tris (pH 8.8) and 0.1 % Triton 
X-100 and 3 X 6 min bead beating to lyse yeast cells, optimal labeling (Lane 3 of Figure 
14(a) and Lane 4 of Figure 14(4)) with distinct bright bands on the SDS-PAGE gel were 
achieved. Addition of probe was carried out only after purification of the lysate (after 
ultracentrifugation), and not during the lysis bead beating step (compare Lane 3 and 4 of 
Figure 14(a)).  
It is noteworthy that when cells are lysed, proteases are liberated (North M.J., 1989). 
Hence all, if not most, lysis buffer contain protease inhibitor like PMSF or protease inhibitor 
cocktail (which include leupeptin, pepstatin, aprotinin and besatatin). Since most of these 
protease inhibitors inactivate serine proteases or cysteine proteases (North M.J., 1989), 
which is our proteins of interest, we do not include them in our lysis buffer. Instead, to 
prevent autolysis or proteolysis of other proteases, sample preparation step was carried out 
at low temperature (4 oC) which proteases are less active. 
After sample preparation step has been optimized, gel-based separation was moved 
from one dimensional SDS-PAGE to 2D-GE gel. In Figure 15 and Figure 16, it was shown 
that samples obtained from our optimized sample preparation method gave distinct 
fluorescent spots on 2D gel with minimal streaking. During the first dimension IEF, voltage 
increased steadily to the final desired focusing voltage (8000 V), this provides evidence that 
the sample composition was compatible and did not interfere with the focusing step. In 
Figure 15, a labeled yeast sample (without going through IEF) was ran along side with a 2D 
sample. In the box in Figure 15, a thick band in 1D sample was found to make up of 2 spots 
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on a 2D gel. This clearly demonstrate the undisputable fact that 2D-GE has a better 
resolution power than a normal 1D SDS-PAGE., and also a reason why all our ABP 
labeling was detected in 2D, and not 1D as reported by the rest (Jessani N. et al., 2002; 
Speers A.E. et al., 2003).  
The 2D gel shown in Figure 16 (a) was stained with a total-protein dye, SYPRO 
ruby protein stain, and 1000-2000 proteins were readily detected (Figure 16(b)). This 
demonstrates that our optimized sample preparation method has extracted a good amount of 
proteins, which was a common standard detected in most other 2D-GE experiments(Gygi 
S.P. et al., 2000; Hu Y. et al., 2003). In the enlarged portion of the overlapped gel image 
(Figure 16(c)), FP-Cy5 labeled protein was also stained by SYPRO ruby (yellow spots), this 
showed that the labeled proteins was part of the proteome and in this case was one of the 
low abundance proteins. 
Effective labeling of proteins with ABP and a well separated fluorescent 2D gel has 
showed that we have successfully optimized a sample preparation method, which extract a 
reasonable amount of active proteins and is compatible to 2D-GE.  
 
4.3 Identification of serine hydrolases in a yeast proteome 
An ideal scenario to identify serine hydrolase from the yeast proteome will be to get 
a hit protein from MS result obtain directly from an excised fluorescent spot. But this was 
not the case, because since the fluorescent probe is much more sensitive (10-16) than the 
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detection range of MS (10-14), proteins detected by the fluorescent probe may not be able 
to analyze by normal MS.  
Multiple attempts were made to increase the fluorescently labeled protein 
concentration so as to be sufficient for MS analysis, these include increasing protein loads 
into each 2D gel and combining same spots from 3 similar fluorescent gels, but all this 
were in vain. This problem is within our expectation, because since ABP only target a 
sub-class of the entire proteome, there is a possibility that they were made up of low 
abundance proteins, and this could be demonstrate by the faintly SYPRO ruby labeled 
spot in Figure 16 (c). 
To circumvent this problem, FP-biotin was used. This probe consists of the same 
reactive unit, which target serine hydrolase, as FP-Cy5 but the fluorescent tag unit was 
replaced by a biotin tag. Although we have previously discussed the advantages of 
fluorescent mode of detection over the biotin-avidin system, but in this case, the latter 
system is able to concentrate and purify biotinylated probe labeled-proteins by affinity 
purification with streptavidin beads, which will provide us with sufficient amount of 
protein concentration for MS analysis. Moreover, it has been shown by Patricelli MP . et 
al (2001) that both fluorescent and biotinylated FP-probes appeared to react with similar 
sets of proteins. 
During affinity purification, stringent washes were carried out to wash away 
unbound/unlabeled proteins or proteins which unspecifically bind to streptavidin beads. A 
control 2D gel (Figure 17 (b)) with unlabeled yeast lysate going through similar affinity 
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purification showed that there was no unspecific protein and good washings had been 
achieved. Therefore, we can confidently conclude that the spots in Figure 17 (a) are serine 
hydrolases that were labeled by FP-biotin and affinity purified by streptavidin beads. 
A total of 4 spots with strong silver staining were excised from the gel shown in 
Figure 17 (a). One of the spot was identified as subtilisin-like protease III, and a search 
through database confirmed that this protein is a known serine hydrolase (Siezen RJ et al, 
1997). This protease belongs to peptidase family S8 (subtilisin family, clan SB). To date, 
this family is the second largest serine protease family with over 200 known subtilases, of 
which 170 has complete amino acid sequences (Siezen R.J. et al, 1997). These proteases are 
found in viruses, eubacteria, archaebacteria and eukaryotes (Barrett A.J. & Rawlings N.D., 
1994). Structures for several members of the subtilisin family have been determined and it is 
shown that they employ the same catalytic triad (aspartic acid (D), serine (S) and 
histidine(H)) as the chymotrypsins, although the residues occur in a different order (HDS in 
chymotrypsin and DHS in subtilisin) (Barrett A.J. & Rawlings N.D., 1993; 1994) 
 
 Two other spots (6 and 8 in Figure 17 (a)) that have been identified were of the 
same protein, vesicular transport protein sec17. This protein is a peripheral membrane 
protein that is needed for vesicular transport between endoplasmic reticulum (ER) and Golgi 
apparatus (Griff I.C. et al., 1992). No known report was found to indicate that this protein is 
a serine hydrolase, but another component of the ER translocation site, sec11 has been 
classified to be a serine peptidase in peptidase family S26 (http://us.expasy.org/cgi-
bin/niceprot.pl?P15367). In yeast, protein Sec11 is required for the cleavage of signal 
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peptides of nascent polypeptide chains during their passage through translocation sites. 
(Bohni P.C. et al., 1988), and this activity is mediated by a serine/histidine dyad (Barrett 
A.J. & Rawlings N.D., 1994). Interestingly, a protein sequence alignment showed that sec17 
shared 12.6 % homology with sec11 (Figure 18), hence we speculate that there might be a 
possibility that sec17 is a serine hydrolase. Further assay like standard protein chemistry 
techniques using diisopropyl fluorophosphates (DIFP) (Scaloni A.J. et al., 1992) may be 
carry out to confirm this point. 
 
 The last spot identified in the yeast proteome is a hypothetical protein that has been 
describe by Saccharomyces Genome Database to be in the yeast mitochondrial proteome 
with unknown biological function. (http://db.yeastgenome.org/cgi-
bin/SGD/locus.pl?locus=fmp13). Like wise, more assays need to be carried out to 
characterize this possible novel proteins. 
 
 
4.4 Differential profiling of serine hydrolases 
4.4.1 Proof of concept  
In this proof of concept experiment, we artificially induced over-expression of a 
serine hydrolase in a bacteria system, and by differentially labeling and comparing it with 
a non-induced bacteria system, the over-expressed protein were detected. 
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First and foremost, YSP3, a known serine hydrolase (Siezen R.J. et al, 1997) which 
has been previously identified by us (described earlier) via FP-biotin labeling, was chosen 
as the protein of interest. YSP3 gene was taken from a yeast ex-clone (Invitrogen), and was 
cloned into GatewayTM system. This technology provides a rapid and highly efficient route 
to protein expression, functional analysis and cloning/subcloning of DNA segments. In a 
nut shell, the gene was cloned into a donor vector (Figure 19) then into a bacterial 
destination vectors, and the resulting expression clone was subsequently transform into a 
bacterial expression host BL 21(AI) for induced expression of the protein of interest. The 
most valuable asset of doing cloning in Gateway is the ability to shuttle and transfer the 
genes cloned into the entry vector to any of the Gateway compatible vectors efficiently and 
rapidly. Unlike conventional restriction enzyme digestion and ligation method, subcloning 
of the inserted gene requires the repeat of the laborious steps in selection of cloning sites, 
purification, large scale screening and sequencing. 
Sequencing results (Figure 21) showed that YSP3 gene has been successfully cloned 
into the bacterial expression host BL21 (AI), which has no known endogenous homologous 
YSP3 proteins. The gene was under the regulatory control of the T7 promoter for controlled 
induction and expression. In BL21 (AI), a cassette containing the T7 RNA polymerase (T7 
RNAP) and tetA genes in the araB locus were inserted into the chromosome. Thus the 
expression of T7 polymerase and tetracycline are regulated by the araBAD promoter. L-
arabinose (Lee et al., 1987) was used to induce the araBAD promoter which expresses the 
T7 RNA polymerase. The latter would then catalyze the expression of genes placed under 
the control of the T7 promoter (Figure 34), which in this case is YSP3. In 
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Figure 22Figure 22, a comparison with control BL21 (AI) which was NOT 
transformed by YSP3-containing expression clone (Lane 1) and BL21 (AI) which was 
transformed by YSP3-containing expression clone, but NOT induced by arabinose (Lane2), 
showed that BL21 (AI) which was transformed by YSP3-containing expression clone and 
induced by arabinose (Lane 3) has an additional 52 kD YSP3 band. Taken together, YSP3 
has been successfully cloned into the bacterial expression host and its protein was over- 




Figure 34 Schematic representation of the regulation based on araBAD. AraC in the 
absence of arabinose formed a 210 bp DNA loop, preventing transcription. In the 
presence of arabinose, Ara C released from O2 site, and the loop ceased.   
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Differential serine hydrolase profiling was carried out using FP-Cy3 and FP-Cy5 
to label induced and non-induced lysate respectively, the two samples were quenched, 
mixed and co-separated on a same gel. The gel was scan at different wavelengths to 
visualize Cy3 (green) and Cy5 (red) images. The latter two images were overlapped and 
over-expressed protein YSP3 was observed to be green (Figure 23), while the rest of the 
endogenous serine hydrolases in BL 21 (AI) which were similarly expressed in both 
induced and non-induced lysates were observed to be orange (red plus green) colour. 
This proof of concept experiment confirmed two points. First, since YSP3 is a 
known serine hydrolases, and it was labeled and identified by FP-probe (Figure 22, Table 
1), this invariably further confirmed that FP-probe targets serine hydrolases in a complex 
proteome. Second, using the combination of ABP + DIGE, we are able to differentially 
profile a subset of a proteome, which in this case is the serine hydrolase class of enzymes, 
from two different samples. 
 
4.4.2 Differential profiling of serine hydrolases in normal and apoptotic cells 
The strategy of ABP + DIGE is further put forward to profile serine hydrolase 
expression between normal and apoptotic cells. It has been reported by Grabarek J. et al. 
(2002) that serine hydrolase(s) were activated during apoptosis, and they proposed to name 
these proteases serpases. In this part of the experiment, HeLa cells were induced to be 
apoptotic by exposure to UV in the middle wave length range (290-320 nM, UVB) 
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(Isoherranen K. et al., 1999). In this ABP + DIGE experiment, UVB-induced HeLa cells 
and non-induced cells were labeled with FP-Cy3 (green) and FP-Cy5 (red) respectively. In 
an overlapped gel image (Figure 25), the greater number of reddish orange spots showed 
that majority of the serine hydrolases labeled were slightly down-regulated in apoptotic 
cells, this is in contrast of what was reported by Grabarek J. et al. (2002). On the other hand, 
only one spot (circled in Figure 25) were distinctly up-regulated in apoptotic cells. 
 A possible explanation to this contrasting result may be due to different mode of 
detection of serine hydrolases. In the paper by Garbarek J. et al. (2002), they reported the 
use of 5(6)-carboxyfluoresceinyl-L-phenylalanyl-chloromethyl ketone (FFCK), which is a 
fluorochrome-labeled analog of N-tosyl-Lphenylalanine chloromethyl ketone (TPCK), the 
inhibitor known to specifically and covalently bind to the active center of chymotrypsin-
like enzymes. Normal and apoptotic cells were labeled with FFCK and identified by 
fluorescence microscopy and laser scanning cytometry. In their scattergrams, it was 
clearly shown that more apoptotic cells were fluorescently detected. The pitfall of their 
experiment is their mode of detection, which only reports overall increase in all serine 
proteases in the cell and not individual serine proteases. If majority of the serine proteases 
were slightly down-regulated during apoptosis in a cell, and only a handful of them are 
strongly up-regulated (which is the case detected by us as shown in Figure 25), most 
possibly it will be scored as a fluorescent cell in their experiment.  
On the other hand, using DIGE + ABP, changes in individual serine hydrolases can 
be assessed. Although in our experiment only one serine hydrolase was detected to be up-
regulated during apoptosis (Figure 25), but we do not dispute that there might be more than 
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one, as some serine hydrolases might be lost during sample preparation step. Nevertheless, 
using gel-based separation as the platform, DIGE + ABP definitely give a clearer picture of 
differential expression of serine proteases from two different samples. 
Serine hydrolases, which dysfunction have been associated with several diseases 
(Kato G.J. et al, 1999; Declerck Y.A. et al, 1997), have been known to be good drug 
targets in some diseases. Current drugs targeted against specific serine hydrolases include 
Angiomax® for cardiovascular disease, Xenical® for obesity, and Aricept® and 
Cognex® for Alzheimer’s disease (http://www.burnham-inst.org/). In addition, serine 
hydrolases have also been identified to be biomarkers for cancer cell invasiveness (Jessani 
N . et al., 2002). Hence unlike conventional DIGE which look at changes in protein 
expression in the whole proteome from 2 samples, using ABP + DIGE, serine hydrolases 
could be specifically detected to be diagnostic markers for various diseases when normal 
and cancer/diseased cells or tissues are compared. Subsequent identification of the serine 
hydrolases by coupling the strategy with FP-biotin, offers a powerful means for molecular 
characterization, which can contribute to the area of cancer progression and identification of 
cancer-specific protein markers.  
  71
4.5 In vivo labeling of caspases 
4.5.1 In vivo labeling of caspases 
 A typical affinity probe for caspases which can be obtain commercially, normally 
comprises of a known caspase inhibitor, a tetrapeptide linker which can be fine tune to 
target a specific caspase, and a tag unit like biotin or a fluorescent tag (eg 
caroxyfluorescein (FAM)).  Fluoromethylketone (fmk)-containing tetrapeptides are well-
documented examples known to covalently react with the active site residues in many 
cysteine proteases (Rasnick D., 1985; Otto HH . et al., 1997).  An example will be FAM-
DEVD-FMK which specifically fluorescently labels caspase-3 (tetrapeptide is underlined).  
 
Characterizing a protein inside the living cell is crucial to a detailed understanding 
of its function. In this part of the project, we aimed to label all caspases in vivo. Hence the 
probe generated by my colleague for this purpose has two mian differences from the rest 
of the caspase affinity probe. First, to label all caspases, the linker unit of the probe was 
comprised of a simple alkyl chain, which is approximately the length of the P2–P4 
tripeptide sequence in a typical caspase inhibitor, and yet does not impose any specificity 
upon a particular caspase (Liau . et al., 2003). Second, the tag units used were fluorescein 
and biotin. These two small molecules have been reported to be able to permeate cells and 
enable in vivo labeling (Keppler A . et al., 2003). The probes which were generated were 
caspase-fluorescein and caspase-biotin. Caspase-fluorescein is made up of a known caspase 
inhibitor (fluoromethylketone) (Rasnick D., 1985; Otto H.H. et al., 1997) and a fluorescein 
diacetate tag. When fluorescein is protected as the diacetate, it becomes nonpolar enough to 
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bring the whole probe passively cross the plasma membrane of living cells. Since most 
mammalian cells have some amount of esterase activity in the cytosol, the intracellular dye 
is cleaved back to fluorescein, giving bright green fluorescence. As for caspase-biotin probe, 
the use of biotin as a small molecule to form non-covalent bond with the protein (contain 
biotin acceptor domains) in the cell has been reported in many instances (Wu M.M. et al., 
2000; Cronan J.E. et al., 1990; Smith P.A. et al., 1998). 
A few experiments were carried out to test the feasibility of our probes to label 
caspases in vivo. In a comparison experiment, the cells were labeled in vivo with caspase-
fluorescein and fluorescein dye (with no reactive and linker unit), it is expected that the 
latter, being not targeted to bind to any protein got washed off after several washing steps 
(Figure 26(b)). On the contrary, caspase-fluorescein was not washed off, cells were 
observed to fluorest brightly (Figure 26 (a)), indicating that the probe not only enters the 
cells but also binds to proteins that were in the cells.  
Labeling experiment was further extended to cells at different time point after they 
were UVB irradiated. 2D gels of the labeled lysates (Figure 29) showed that as the cells 
became apoptotic (6 hours after UVB irradiation), the labeled proteins became more intense. 
This is true for the case of caspases, which were synthesized as zymogen and were activated 
only at the onset of apoptosis (Earnshaw W.C. et al., 1999). And indeed, in a preliminary 
experiment using caspase-biotin labeling and affinity purification, caspase-8 were identified. 
But only one protein has been identified in this small scale experiment, this prompted us to a 
future experiment of labeling large scale apoptotic cells to identify all the proteins that were 
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labeled by caspase-biotin. In a similar experiment conducted by Faleiro L. et al. (1997), 
they reported affinity purification of caspases by in vitro labeling using biotin-YVAD-amk 
probe. A total of 68 L of Jurkat cells were used, which is drastically more than what was 
used in our experiment (2 L). 
One important point to note is, labeling was surprisingly observed in non-apoptotic 
cells (Figure 26, Figure 27). This should not be the case since caspases are in non-active 
zymogen form in normal cells, and it has been reported that affinity label like biotin-
YVAD-amk do not label non-apoptotic cells (Faleiro L. et al., 1997). This led us to 
speculate that while the probe is synthesized to target a general class of caspases, it seems to 
target other proteins also. A recent report by Rozman-Pungercar J. et al. (2003) probably 
explain this phenomena, they showed that caspase inhibitors that consist of caspase 
recognition sequence linked to chloromethylketone, FMK or aldehyde reactive group 
efficiently inhibit other cysteine proteases in addition to caspases. Their results propose that 
data based on the use of these inhibitors should be interpreted with care and that other 
proteases may be involved in the processes previously ascribed solely to caspases. 
 
4.5.2 In vivo labeling of caspase-associated substrates 
In a separate caspase-biotin affinity labeling experiment, using a less stringent 
washing condition and a milder elution steps, a lot of unspecific proteins were eluted from 
the streptavidin beads. This was evident by the similar spots obtained by both caspase-biotin 
  74
labeled- and unlabeled- sample. An interesting finding is, additional spots which were found 
only in labeled samples, a majority of them are identified to be/related to caspase substrates. 
A total of 8 proteins were identified, and they were broadly classified into 3 groups: (1) 
known caspase substrate, (2) proteins with shared homology/associated with caspase 
substrates and (3) proteins with no known link to caspases. 
 In the first group which made up of known caspase substrates, it comprises of actin 
(Kayalar C. et al., 1996; Chen Z. et al., 1996) and proteasome activator 28 subunit γ 
(PA28γ). Caspases have been reported to destroy several cytoskeletal proteins like actin 
and cytokeratin, this may be directly link to the collapse of cell morphology during 
apoptosis. As for the PA28γ, although interaction of caspases with other proteases like 
proteasome is poorly understood, but it has been shown in a yeast two-hybrid screening 
using constitutive-active caspase-7 as bait, PA28γ is an effector caspase substrate (Araya R. 
et al, 2002).  
 
 In the second group which made up of proteins that share homology or are associated 
to known caspase substrates, it comprises of T-cell receptor beta chain C region and GTP-
binding nuclear protein RAN. For the former, its close cousin, T-cell receptor zeta-chain 
has been reported by Gastman B.R. et al. (1999) that it was bound and subsequently 
degraded by caspase. As for GTP-binding nuclear protein RAN, its associating Ran 




The last group of protein which has no link to caspases or its substrates, were 
surprisingly all made up of glycolysis-related proteins like glyceraldehyde 3-phosphate 
dehydrogenase, fructose-bisphosphate aldolase A and alpha enolase. Glycolysis (energy-
providing glucose breakdown) and apoptosis has long been viewed as two separate 
pathways. But recently, a combination of genetics, proteomics and physiological 
techniques may have changed that picture. BAD protein is an apoptosis inducer associated 
with BCL2 and BAX, two of the family of Bcl2-encoded proteins that regulate cell 
survival and cell death in many tissues. And BAD has now been reported by Danial N.N. 
et al. (2003) to be a component of an enzyme complex in mouse liver mitochondria that 
also contains a glucokinase. This complex is necessary to maintain glucose homeostasis 
and to connect cellular metabolism and apoptosis.  
Taken together, using this less stringent washing condition and milder elution step, 
none of the spots were identified to be caspases, but a large number of them are or related to 
caspase substrates. We hypothesise that  after the less stringent washing steps, caspase 
substrates are still bound to caspases, and instead of eluting caspases (with ABP) from the 
streptavidin beads, only caspase substrate which bind covalently to the caspases were eluted 
(Figure 35), leaving the caspases still bound to the streptavidin beads. This hypothesis is 
confirmed by Kilic M. et al. (2002), they reported that using affinity label YVK(-
bio)D.aomk that specifically label caspase-3, -6 and -2, high molecular weight (600kDa for 











         
Figure 35 A possible scenario in the less stringent condition. Red arrow showed desired 
cleavage site, while black arrow show possible cleavage site during mild elution step. 
In this second part of the experiment, preliminary results with these probes 
(caspase-fluorescein and caspase-biotin) indicated that they were highly cell-permeable 
and capable of efficient labeling of caspases expressed inside apoptotic HeLa cells.  This 
method may allow further studies of different caspase activation cascades, as well as their 
involvements in apoptosis-related diseases. 
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4.6 Activity-based profiling 
As far as most enzymes are concerned, their overall expression profiles (based on 
the absolute amount of proteins expressed) do not strictly equate to their activity profiles 
(based on the enzymatic activity of expressed proteins), because different enzymes 
intrinsically have differing catalytic activities.  In addition, post-translational modifications 
(phosphorylation, acetylation, or glycosylation etc.), endogenous activators/inhibitors, pH 
and other environmental conditions often influence the activity of an enzyme.  Accordingly, 
enzymes play critical roles in modulating a variety of biological processes through the fine 
control of their catalytic activities not simply by their absolute expression levels, but more 
importantly, by their overall enzymatic activity at a well-defined time and location.  
Consequently, activity-based enzyme profiling could potentially reveal more insights into 
how an enzyme is related to a particular biological event.   
We have developed a functional subproteomic methodology that specifically 
profiles certain classes of enzymes (serine hydrolases and caspases). Collectively, the 
strategy we employed combined the use of activity-based probes, two-dimensional gel 
electrophoresis- mass spectrometry (2DE-MS) and differential in-gel electrophoresis 
(DIGE), thereby exploiting their individual advantages. For example, since ABP usually 
made up of inhibitors or mechanism-based substrates which have a relatively high affinity 
to their respective enzymes, we can be sure that labeling is carried out only to active 
enzymes. And tag unit in ABP facilitates sensitive detection, quantitation, isolation and the 
subsequent identification of enzymes upon their labeling by the probe. On top of that, using 
DIGE as the platform, traditional 2D gel limitations, like gel superimposibility, are 
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overcome. Differential expression between 2 samples can be rapidly profiled and with high 
sensitivity. 
However, a fundamental hurdle in our strategy, which uses two types of ABP to 
fulfil complementary objectives: fluorescent probes for rapid and sensitive target detection 
and biotinylated probes for target purification and identification, is we can never be 100 % 
sure that the spots from biotinylated probe purification are indeed true positive (although 
negative control are always ran in parallel). Hence, using a trifunctional chemical probe as 
reported by Adam G.C. et al. (2002b) will be an alternative. In this probe, the advantages of 
different types of tags were exploited by having multiple tag units within the same small 
molecule probe.  For example, the probe reported by them contains a reactive unit and two 
tag units (i.e. a fluorescent rhodamine tag and a biotin tag). It was shown that, proteins 
labeled with this probe could be detected rapidly and with high sensitivity by a fluorescence 
scanner, and then subsequently purified and enriched, without any further modifications, by 
avidin-containing agarose beads.  The improved advantage of this probe for activity-based 
profiling of proteins was demonstrated by its ability to detect an integral membrane enzyme 
and two cofactor-dependent enzymes, which were not previously detected in a similar 
experiment with a probe having a single tag unit.   
 
There are, however, other challenges associated with ABP that remained to be 
resolved.  Firstly, the limited number of probes currently available, especially for in vivo 
studies, restricts the application of this technology to the study of only limited classes of 
enzymes.  Secondly, potential interferences in the labeling reaction due to the linker/tag 
units have yet to be studied thoroughly. Finally, in most ABP experiments published thus 
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far, only a handful of all labeled proteins were identified, characterized and reported.  Hence 
the selectivity of the probes is far from clear.  Ideally, all labeled proteins in an ABP 
experiment should be identified and reported without any bias.   
To date, there is not a single technique that can provide all the information on the 
different properties of proteins present in a proteome.  Proteomics strategies utilizing ABP 
have opened up new ways in answering some of the challenges associated with proteomics 
research.  Most of the results elaborated in this project provided only proof-of-concept 
experiments, such as in vitro and in vivo profilings of enzymes activities.  It is our vision 
that, one day, possibly all enzymes or enzymes classes may be studied, both in vitro and in 
vivo, using similar technologies in a truly large-scale, high-throughput proteomics 







C h a p t e r  5  
CONCLUSION 
We have developed a functional subproteomic methodology that specifically 
profiles certain classes of enzymes (serine hydrolases and caspases). This strategy combined 
the use of ABP, two-dimensional gel electrophoresis- mass spectrometry (2DE-MS) and 
differential in-gel electrophoresis (DIGE) to profile subproteomic expression in normal and 
apoptotic HeLa cells.  
Sample preparation step was optimized for 2D gel-based activity profiling. Using 
this optimized step, a known yeast serine hydrolase (YSP3) was purified by FP-biotin. In a 
proof-of-concept experiment, artificially over-induction of YSP3 was detected in ABP + 
DIGE strategy. This strategy was further put forth in profiling differential expression of 
serine hydrolases between normal and apoptotic cells.  
In another part of the project, preliminary results using caspase-fluorescein and 
caspase-biotin indicated that they were highly cell-permeable and capable of efficient 
labeling of caspases expressed inside apoptotic HeLa cells. We have identified caspase-8 in 
the initial round of experiment. 
In conclusion, using ABP, we could not only greatly accelerate the assignment of 
protein function and the identification of potential pharmaceutical targets, but also make it 
possible to study the whole human proteome by looking at different classes of proteins, 
one class at a time.  
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7. 1 MALDI-TOF mass spectra of tryptic peptides derived from yeast proteins ( 
Table 1) labeled by FP-biotin and their peptide alignment sequences. 
7.1.1 Subtilisin-like protease III 
 


































      
     1 MKFSTILPIL WANCCLCMII PEFDGIVRFI ENIDGTRSVR AGEGLGQHDP  
    51 GNFHTEHQHV AHKTEFLPYR YVIVFNEDIS LQQIQSHMQV VQKDHSTSVG  
   101 KLTEDDAFWR VISSSVSSKS QFGGIDNFFD INGLFRGYTG YFTDEIIKII  
   151 SQDPIIKFVE QETTVKISNS SLQEEAPWGL HRVSHREKGV TSYVLDTGID  
   201 TEHEDFEGRA EWGAVIPAND EASDLNGHGT HCAGIIGSKH FGVAKNTKIV  
   251 AVKVLRSNGE GTVSDVIKGI ELVTKEHIES SKKKNKEFKG STANLSLGSS  
   301 KSLAMEMAVN AAVDSGVHFA IAAGNEDEDA CLSSPAGAEK SITVGASTFS  
   351 DDRAFFSNWG TCVDVFAPGI NIMSTYIGSR NATLSLSGTS MASPHVAGIL  
   401 SYFLSLQPAP DSEFFNDAPS PQELKEKVLK FSTQGVLGDI GDDTPNKLIY  
   451 NGGGKKLDGF W 
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1293.01111475.7542994.4239 1977.89961839.94941124.3915 1657.90351470.5940 2370.11982071.1285 2651.4557
 
 
     
 
 
     1 ISDPVELLKR AEKKGVPSSG FMKLFSGSDS YKFEEAADLC VQAATIYRLR  
    51 KELNLAGDSF LKAADYQKKA GNEDEAGNTY VEAYKCFKSG GNSVNAVDSL  
   101 ENAIQIFTHR GQFRRGANFK FELGEILEND LHDYAKAIDC YELAGEWYAQ  
   151 DQSVALSNKC FIKCADLKAL DGQYIEASDI YSKLIKSSMG NRLSQWSLKD  
   201 YFLKKGLCQL AATDAVAAAR TLQEGQSEDP NFADSRESNF LKSLIDAVNE  





7.1.3 Hypothetical 61.1 kDa protein in YPT52-DBP7 intergenic region 
 
 



































     1 MMLRTTASRK IVLRRGLASI NTGTTVASKK ASHKFRNTLW TIALSATAFY  
    51 AGGIIYSQKN DKFGDFFSNN VPFAEDLLET YEHYHDRPTL FLEDSWDGLK  
   101 AKSNDLLSGL TGSSQTRRSN RENIEVKKIL SLEPLNIETE NSDPQLKEII  
   151 GSLNDLINSL NDSNLSIPES EFNSIKKSNQ NMLTNLSQLN ETLKEALSNY  
   201 MIQRTSEVIT ELNTQYENSK REFEKNLQKN LLQEVDEFKE NLTKQKDKEL  
   251 EEKLKANEEL LQAKHANEVG LLSITQVKEF NKIIKDKIEK ERNGRLAHLE  
   301 EINSEVNDLS KSIDRSSKIL SKNEALVQLT FQVDEIKSRI NNNNLPDVNI  
   351 DKELSRLKLL SNLLSTFNKK SCCDDGDCCS CKKGNKNEGK EGKISCKCKP  
   401 KTNPPSLLSV ALDELESTCS GKKILSNEQI YNRWNLLADD FKTASLLPPN  
   451 SGILGQLTAK VFSLFLFTKT GNPSNATDFD SVYARVGDNL RVSNLNDAVE  
   501 EVVSLKGWPH KVCESWIEDA RRKLEVQRLV EILDCEIRTL  
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7. 2 MALDI-TOF mass spectra of tryptic peptides derived from yeast proteins (Table 2) 
labeled by caspase-biotin and their peptide alignment sequences. 
 
7.2.1 Glyceraldehyde 3-phosphate dehydrogenase 




















Voyager Spec #1=>BC=>NR(2.00)[BP = 1763.8, 11407]
Mass (m/z)



























































































1006.2860 1707.80671167.3396 1320.5863 2808.4127
Spot number:4 
 
     1 MGKVKVGVNG FGRIGRLVTR AAFNSGKVDI VAINDPFIDL NYMVYMFQYD  
    51 STHGKFHGTV KAENGKLVIN GNPITIFQER DPSKIKWGDA GAEYVVESTG  
   101 VFTTMEKAGA HLQGGAKRVI ISAPSADAPM FVMGVNHEKY DNSLKIISNA  
   151 SCTTNCLAPL AKVIHDNFGI VEGLMTTVHA ITATQKTVDG PSGKLWRDGR  
   201 GALQNIIPAS TGAAKAVGKV IPELNGKLTG MAFRVPTANV SVVDLTCRLE  
   251 KPAKYDDIKK VVKQASEGPL KGILGYTEHQ VVSSDFNSDT HSSTFDAGAG  










































1434.7274909.2355 2228.07471059.2807 1791.8986 2061.2680
     1 MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE  
    51 NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS  
   101 KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC  
   151 VLKIGEHTPS ALAIMENANV LARYASICQQ NGIVPIVEPE ILPDGDHDLK  
   201 RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA  
   251 MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF  
   301 SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG  




7.2.3 GTP-binding nuclear protein RAN 





























     1 GDASGRNAAM AAQGEPQVQF KLVLVGDGGT GKTTFVKRHL TGEFEKKYVA  
    51 TLGVEVHPLV FHTNRGPIKF NVWDTAGQEK FGGLRDGYYI QAQCAIIMFD  
   101 VTSRVTYKNV PNWHRDLVRV CENIPIVLCG NKVDIKDRKV KAKSIVFHRK  
   151 KNLQYYDISA KSNYNFEKPF LWLARKLIGD PNLEFVAMPA LAPPEVVMDP  
   201 ALAAQYEHDL EVAQTTALPD EDDDL 
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7.2.4 Peptidyl-prolyl cis-trans isomerase A 
























1831.98071001.3161 1550.80311139.4189 1380.7684 2793.51941707.8497 1961.0250 2580.82122286.9972 3313.5478
 
 
     1 MVNPTVFFDI AVDGEPLGRV SFELFADKVP KTAENFRALS TGEKGFGYKG  
    51 SCFHRIIPGF MCQGGDFTRH NGTGGKSIYG EKFEDENFIL KHTGPGILSM  
   101 ANAGPNTNGS QFFICTAKTE WLDGKHVVFG KVKEGMNIVE AMERFGSRNG  
   151 KTSKKITIAD CGQLE 
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1556.7395 2176.07441910.3297 2501.24741035.2904 1707.7654 2354.1523
1076.3655 1864.8237 3013.6418 3313.36811240.7694 1525.7715 2807.43712286.11831032.7092 1807.44991389.67361177.2292 2130.30291552.5767 2692.20682273.3088 2505.06981968.64101369.3776 2833.12171795.96491238.3901 2118.74041606.7210 3016.88072697.57992277.0749 2566.05912418.26971960.9884 2857.8353 3349.69343156.23753019.7749 3357.7058















     1 MSILKIHARE IFDSRGNPTV EVDLFTSKGL FRAAVPSGAS TGIYEALELR   
    51 DNDKTRYMGK GVSKAVEHIN KTIAPALVSK KLNVTEQEKI DKLMIEMDGT  
   101 ENKSKFGANA ILGVSLAVCK AGAVEKGVPL YRHIADLAGN SEVILPVPAF  
   151 NVINGGSHAG NKLAMQEFMI LPVGAANFRE AMR  IGAEVYH NLKNVIKEKY 
   201 GKDATNVGDE GGFAPNILEN KEGLELLKTA IGKAGYTDKV VIGMDVAASE  
   251 FFRSGKYDLD FKSPDDPSRY ISPDQLADLY KSFIKDYPVV SIEDPFDQDD  
   301 WGAWQKFTAS AGIQVVGDDL TVTNPKRIAK AVNEKSCNCL LLKVNQIGSV  
   351 TESLQACKLA QANGWGVMVS HRSGETEDTF IADLVVGLCT GQIKTGAPCR  




7.2.6 Actin, beta 
 



























1023.3268 1547.77091267.7241 3137.77711045.3422 1960.9411 2169.3587
 
     1 LVVDNGSGMC KAGFAGDDAP RAVFPSIVGR PRHQGVMVGM GQKDSYVGDE  
    51 AQSKRGILTL KYPIEHGIVT NWDDMEKIWH HTFYNELRVA PEEHPVLLTE  
   101 APLNPKANRE KMTQIMFETF NTPAMYVAIQ AVLSLYASGR TTGIVMDSGD  
   151 GVTHTVPIYE GYALPHAILR LDLAGRDLTD YLMKILTERG YSFTTTAERE  
   201 IVRDIKEKLC YVALDFEQEM ATAASSSSLE KSYELPDGQV ITIGNERFRC  
   251 PEALFQPSFL GMESCGIHET TFNSIMKCDV DIRKDLYANT VLSGGTTMYP  
   301 GIADRMQKEI TALAPSTMKI KIIAPPERKY SVWIGGSILA SLSTFQQMWI  





7.2.7 Proteasome activator complex subunit 3 
 






















Voyager Spec #1=>BC=>NR(2.00)[BP = 1337.7, 21698]
1337.7125
1468.7678 1883.98991293.73041066.0811 1706.34861434.8280 1973.2570 2920.80772179.5928 2443.1910
  
    1 MASLLKVDQE VKLKVDSFRE RITSEAEDLV ANFFPKKLLE LDSFLKEPIL  
    51 NIHDLTQIHS DMNLPVPDPI LLTNSHDGLD GPTYKKRRLD ECEEAFQGTK  
   101 VFVMPNGMLK SNQQLVDIIE KVKPEIRLLI EKCNTPSGKG PHICFDLQVK  
   151 MWVQLLIPRI EDGNNFGVSI QEETVAELRT VESEAASYLD QISRYYITRA  
   201 KLVSKIAKYP HVEDYRRTVT EIDEKEYISL RLIISELRNQ YVTLHDMILK  










     1 NVPIDDSGMP EDRFSAKMPN ASFSTLKIQP SEPRDSAVYF CASSFDRGNS  
    51 YEQYFGPGTR LTVTEDL




























Voyager Spec #1=>BC=>NR(2.00)[BP = 1267.7, 26096]
1267.7220
1383.8101
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